Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
172 hedge funds and large institutions have $1.77B invested in Silk Road Medical, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 73 increasing their positions, 53 reducing their positions, and 41 closing their positions.
105,760% more call options, than puts
Call options by funds: $5.29M | Put options by funds: $5K
38% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 53
7% less funds holding
Funds holding: 185 → 172 (-13)
20% less capital invested
Capital invested by funds: $2.21B → $1.77B (-$441M)
32% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$43.7M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$34.3M |
| 3 |
DM
Deerfield Management
New York
|
+$20.9M |
| 4 |
ClearBridge Investments
New York
|
+$19.5M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$42.3M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$31.9M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$25.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$23.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$21.7M |
SILK Hedge Fund Activity: Q1 2021 in Review
172 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q1 2021, worth a combined $1.77B — down 20% from $2.21B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of SILK and 28 opened new positions — a net loss of 13 holders — while 53 trimmed existing stakes and 73 added.
The largest buyer was Bellevue Group, adding an estimated $43.7M. The largest seller was Jennison Associates, cutting an estimated $42.3M.
- 172 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q1 2021, down from 185 in Q4 2020.
- Funds reported $1.77B of Silk Road Medical, Inc. Common Stock stock for Q1 2021, down 20% quarter-over-quarter.
- 28 funds opened new Silk Road Medical, Inc. Common Stock positions in Q1 2021 and 41 closed out, a net change of -13 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q1 2021 was Bellevue Group, an estimated $43.7M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q1 2021 was Jennison Associates, an estimated $42.3M sold.
Based on aggregated 13F filings for Q1 2021.